Teva Pharmaceutical Industries Ltd v Mylan Pharmaceuticals ULC

Counsel to Mylan in defending a NOC proceeding relating to a composition of matter patent over COPAXONE® (glatiramer acetate – a random polypeptide), the first and only Canadian generic challenge to COPAXONE®. Teva and Mylan also litigated in the U.S., U.K., Netherlands, and elsewhere over this blockbuster product. (Prior to joining Lenczner Slaght)